Vandazole Patent Expiration

Vandazole is a drug owned by Teva Pharmaceuticals Usa. It is protected by 1 US drug patent filed in 2013 out of which none have expired yet. Based on its patents and exclusivities, its generic launch date is estimated to be Sep 22, 2024. Details of Vandazole's patents and their expiration are given in the table below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7456207 Vaginal pharmaceutical compositions and methods for preparing them
Sep, 2024

(2 months from now)


Stay ahead of others in designing the generic launch strategy of these 5 blockbuster drugs expiring in next 5 years.

Get the exclusive patent insights now. Don't be the last to know.

US patents provide insights into the exclusivity only within the United States, but Vandazole is protected by patents in multiple countries. Understanding the full scope of patent protection is crucial in strategizing market entry. By looking at the broader patent landscape, you can identify markets with weaker patent protection which could be ideal generic entry points. The following section offers details on Vandazole's family patents as well as insights into ongoing legal events on those patents.

Vandazole's family patents

Vandazole has patent protection in a total of 1 countries. It has a significant patent presence in the US with 100.0% of its patents being US patents. Click below to unlock the full patent family tree for Vandazole.

Family Patents

Coming Soon

Patent Strength Analyzer

Will this be useful for you?


Thank you for your response 🥳

Generic Launch

Generic Release Date:

Vandazole's generic launch date based on the expiry of its last outstanding patent is estimated to be Sep 22, 2024 (This date is subject to change depending upon the patent filing activities by the drug owner or exclusivity additions to its drug application)

Vandazole Generics:

Metronidazole is the generic name for the brand Vandazole. 37 different companies have already filed for the generic of Vandazole, with Alembic having the maximum number of approved applications. Check out the entire list of companies who have already received approval for Vandazole's generic

About Vandazole

Vandazole is a drug owned by Teva Pharmaceuticals Usa. Vandazole uses Metronidazole as an active ingredient. Vandazole was launched by Teva Pharms in 2005.

Market Authorisation Date:

Vandazole was approved by FDA for market use on 20 May, 2005.

Active Ingredient:

Vandazole uses Metronidazole as the active ingredient. Check out other Drugs and Companies using Metronidazole ingredient


Vandazole is available in gel form for vaginal use. Given below is detailed information on Dosage -

Strength Dosage Form Availability Application Pathway
0.75% GEL Prescription VAGINAL